BROWN; David Tristram

Patent Applications and Registrations

Patent applications and USPTO patent grants for BROWN; David Tristram.The latest application filed is for "novel potassium channel inhibitors".

Company Profile

0.5.7

BROWN; David Tristram - Glostrup DK
Brown; David Tristram - Albertslund DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Potassium Channel Inhibitors App 20220169602 - BROWN; David Tristram ; et al.	2022-06-02
Imidazole derivatives for the treatment of anxiety and related diseases Grant 8,030,339 - Brown , et al. October 4, 2	2011-10-04
Imidazole derivatives and their use for modulating the GABA.sub.A receptor complex Grant 7,939,556 - Brown , et al. May 10, 2	2011-05-10
Imidazole derivatives and their use for modulating the GABA.sub.A receptor complex Grant 7,858,649 - Brown , et al. December 28, 2	2010-12-28
Enantiomers of 3-heteroaryl-8H-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors Grant 7,781,456 - Peters , et al. August 24, 2	2010-08-24
3-aryloxy-8-aza-bicyclo[3.2.1]oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Grant 7,638,532 - Peters , et al. December 29, 2	2009-12-29
Imidazole Derivatives for the Treatment of Anxiety and Related Diseases App 20090233929 - Brown; William Dalby ; et al.	2009-09-17
Imidazole Derivatives And Their Use For Modulating The Gaba Alpha Receptor Complex App 20090209597 - Brown; William Dalby ; et al.	2009-08-20
Imidazole Derivatives and their use for Modulating the Gabaa Receptor Complex App 20090163566 - Brown; William Dalby ; et al.	2009-06-25
3-Aryloxy-8-aza-bicyclo[3.2.1]]oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors App 20090030035 - Peters; Dan ; et al.	2009-01-29
Imidazole Derivatives and Their Use for Modulating the Gabaa Receptor Complex App 20080312303 - Brown; William Dalby ; et al.	2008-12-18
Enantiomers of 3-Heteroaryl-8H-8-Azabicyclo (3.2.1) Oct-2-Ene and their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors App 20080214820 - Peters; Dan ; et al.	2008-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.